Abstract
The endoplasmic reticulum (ER) Hsp70 chaperone BiP is regulated by AMPylation, a reversible inactivating post-translational modification. Both BiP AMPylation and deAMPylation are catalysed by a single ER-localised enzyme, FICD. Here we present crystallographic and solution structures of a deAMPylation Michaelis complex formed between mammalian AMPylated BiP and FICD. The latter, via its tetratricopeptide repeat domain, binds a surface that is specific to ATP-state Hsp70 chaperones, explaining the exquisite selectivity of FICD for BiP’s ATP-bound conformation both when AMPylating and deAMPylating Thr518. The eukaryotic deAMPylation mechanism thus revealed, rationalises the role of the conserved Fic domain Glu234 as a gatekeeper residue that both inhibits AMPylation and facilitates hydrolytic deAMPylation catalysed by dimeric FICD. These findings point to a monomerisation-induced increase in Glu234 flexibility as the basis of an oligomeric state-dependent switch between FICD’s antagonistic activities, despite a similar mode of engagement of its two substrates — unmodified and AMPylated BiP.
Highlights
The endoplasmic reticulum (ER) Hsp[70] chaperone BiP is regulated by AMPylation, a reversible inactivating post-translational modification
BiP AMPylation inversely correlates with the ER protein folding load, increasing upon the inhibition of protein synthesis[6] and with a resolution of ER stress[3]
The recent discovery that the Enterococcus faecalis Fic protein (EfFic) possesses deAMPylation activity which is dependent on a glutamate homologous to FICD’s Glu23412, suggests conservation of the catalytic mechanism amongst Fic enzymes
Summary
The endoplasmic reticulum (ER) Hsp[70] chaperone BiP is regulated by AMPylation, a reversible inactivating post-translational modification. Both BiP AMPylation and deAMPylation are catalysed by a single ER-localised enzyme, FICD. The eukaryotic deAMPylation mechanism revealed, rationalises the role of the conserved Fic domain Glu[234] as a gatekeeper residue that both inhibits AMPylation and facilitates hydrolytic deAMPylation catalysed by dimeric FICD These findings point to a monomerisation-induced increase in Glu[234] flexibility as the basis of an oligomeric statedependent switch between FICD’s antagonistic activities, despite a similar mode of engagement of its two substrates — unmodified and AMPylated BiP. The role of Glu[234] in the oligomeric state-dependent regulation of FICD’s mutually antagonistic activities remains incompletely understood
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have